CD8A and neoplasm: HDACi enhanced the expression of costimulatory molecules, promoted tumor neoantigen presentation, the migration and infiltration of CD8+ T cells into tumors and M1 polarization of macrophages, increased antitumor efficacy of immune checkpoint inhibitor (ICI) [61, 62], and decreased regulatory T cells in TME [63].